Cargando…

Conditional early approval for new drug applications in Japan: Current and emerging issues

Detalles Bibliográficos
Autores principales:	Tanaka, Mototsugu, Miyazawa, Haruna, Terashima, Ryohei, Ikuma, Mutsuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432865/ https://www.ncbi.nlm.nih.gov/pubmed/37161871 http://dx.doi.org/10.1111/cts.13536

Ejemplares similares

Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis
por: Tanaka, Mototsugu, et al.
Publicado: (2020)

Assessment of the impact of Japanese‐specific long‐term safety data on new drug approval
por: Uzu, Shinobu, et al.
Publicado: (2021)

Japan's COVID‐19 treatment strategy: An examination of approved oral medications
por: Higuchi, Yuka, et al.
Publicado: (2023)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

An open science pathway for drug marketing authorization—Registered drug approval
por: Naudet, Florian, et al.
Publicado: (2021)

Challenges and opportunities for improving access to approved neonatal drugs and devices
por: Lewis, Tamorah, et al.
Publicado: (2022)

Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness
por: Abdin, Ahmad Yaman, et al.
Publicado: (2023)

Exposure of Drugs for Hypertension, Diabetes, and Autoimmune Disease During Pregnancy and Perinatal Outcomes: An Investigation of the Regulator in Japan
por: Sato, Ryosuke, et al.
Publicado: (2015)

A Patient‐Centric Model for Discontinuation of a Single‐Sourced Approved Drug
por: Caplan, Arthur, et al.
Publicado: (2019)

Emerging Issues in Virus Taxonomy
por: van Regenmortel, Marc H.V., et al.
Publicado: (2004)

Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
por: Drozda, Katarzyna, et al.
Publicado: (2018)

Lifecycle management of orphan drugs approved in Japan
por: Seki, Kiyoshi, et al.
Publicado: (2022)

An in-silico evaluation of COVID-19 main protease with clinically approved drugs
por: Tachoua, Wafa, et al.
Publicado: (2020)

Pediatric drug development in Japan: Current issues and perspectives
por: Saitou, Hiroyuki, et al.
Publicado: (2020)

First vaccine approval under the FDA Animal Rule
por: Beasley, David W C, et al.
Publicado: (2016)

Regulation of assisted reproductive treatment (ART) in Australia & current ethical issues
por: Johnson, Louise
Publicado: (2014)

Quality by Design risk assessments supporting approved antibody products
por: Kelley, Brian
Publicado: (2016)

The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA.
por: Olivier, Timothée, et al.
Publicado: (2022)

Relationship between menstruation status and work conditions in Japan
por: Nishikitani, Mariko, et al.
Publicado: (2017)

Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance
por: Stratton, Charles W.
Publicado: (2003)

Is legislation to prevent genetic discrimination necessary in Japan? An overview of the current policies and public attitudes
por: Muto, Kaori, et al.
Publicado: (2023)

Expansion of the role of midwives in gender equity and sexual/reproductive health issues in Japan
por: Shimpuku, Yoko
Publicado: (2021)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

The FDA-Approved Essure Device Counseling Order Fails to Promote Patient Empowerment
por: Gunn, Christine M., et al.
Publicado: (2019)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

A Comparison of Safety Information in Drug Labeling at the Initial Approval of New Drugs Approved Both in Japan and the United States
por: Hoshino, Yuko, et al.
Publicado: (2022)

Comparing cancer drug approval systems in the United States and Japan
por: Kaneda, Yudai, et al.
Publicado: (2023)

Feline Host Range of Canine parvovirus: Recent Emergence of New Antigenic Types in Cats
por: Ikeda, Yasuhiro, et al.
Publicado: (2002)

Emerging RAS superfamily conditions involving GTPase function
por: Shieh, Joseph T. C.
Publicado: (2019)

Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015–2020
por: Arondekar, Bhakti, et al.
Publicado: (2022)

Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
por: Constantinescu, Catalin, et al.
Publicado: (2020)

Japan’s Special Approval for Emergency System During the COVID‐19 Pandemic
por: Maeda, Hideki
Publicado: (2021)

Key scientific issues in developing drinking water guidelines for perfluoroalkyl acids: Contaminants of emerging concern
por: Post, Gloria B., et al.
Publicado: (2017)

Cholera outbreak amidst urban flooding in Karachi: An emergency condition
por: Taseen, Shafaq, et al.
Publicado: (2022)

Premarket Approval Through the 510(k) Process: Lessons from the Translation Process of Magnetic Resonance Elastography
por: Aponte Ortiz, Jaime A., et al.
Publicado: (2018)

Regulators' Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia
por: Schuessler‐Lenz, Martina, et al.
Publicado: (2019)

Gynecologic cancer clinical practice guidelines in Korea and current issues
por: Kim, Jeeyeon, et al.
Publicado: (2022)

Cooperation Between Japan’s NIID and China CDC in Japan’s COVID-19 Response
por: Wakita, Takaji
Publicado: (2020)

The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs
por: Vreman, Rick A., et al.
Publicado: (2020)

The hospital exemption pathway for the approval of advanced therapy medicinal products: an underused opportunity? The case of the CAR-T ARI-0001
por: Trias, Esteve, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_101bf3a29bar0ic46cphunl94v